News about <![CDATA[PJP]]> News about en-us <![CDATA[Health Care ETFs Raking in Plenty of Cash]]> ]]> <![CDATA[Pharma ETFs On The Move Again (IHE, PJP, PPH, ACT, FRX)]]> First it was the biotech stocks, now the large pharmaceuticals are getting in on the act.

The two sectors have been attracting money all year and were barely phased by the markets largest pullback in months. The combination of an optimistic view on the pipeline of drugs and an increase

]]>
<![CDATA[Deal for Forest Fantastic for Pharma ETFs]]> ]]> <![CDATA[Three ETFs To Buy On The Pullback (PJP, SKYY, SPY)]]> The stock market pulled back like clockwork over the last few weeks as the S&P 500 fell six percent from an all-time high to the low on Wednesday.

Looking back at the last 15 months, the largest pullback the index suffered was six percent and each time the sell-off hit the

]]>
<![CDATA[Fun With Pharma ETFs]]> ]]> <![CDATA[ETF Winners & Losers from the Ben Bernanke Era]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[Pharma ETFs Could Flatline on Obamacare Bust]]> ]]> <![CDATA[Help From the Hill Could Add to Pharma ETFs’ Gains]]> ]]> <![CDATA[5 ETF Underdogs Beating The Market]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[ETF Categories That Just Keep On Winning]]> ]]> <![CDATA[Pharmaceutical Industry Expected To Collect Billions From Obamacare]]> Despite the technical difficulties and the government shutdown, the Affordable Care Act has launched in most states with others soon to follow.

Primary beneficiaries of the Affordable Care Act are the previously uninsured, who will now enjoy more affordable access to healthcare.

The Affordable Care Act is expected to add 30 million

]]>
<![CDATA[ETFs to Watch September 11, 2013 (DBV, PJP, TBT)]]> Here is the ETF Professor's ETF Watch List for Wednesday, September 11, 2013.

Give the Direxion Daily Energy Bear 3X Shares (NYSE: ERY) a look.

Keep an eye on the First Trust Consumer Staples AlphaDEX Fund (NYSE: FXG).

The PowerShares Dynamic Pharmaceuticals ETF (NYSE: PJP) looks interesting.

]]>
<![CDATA[ETF Insider: Buy On The Dip Prospects September 9th Edition]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[6 ETFs Up After Earnings Season]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[S&P: Heaping Praise For Some Health Care ETFs]]> More than seven months into the year, investors may be running out of superlatives to laud upon health care stocks and ETFs, but adulation is justified. Five of the 10 best-performing non-leveraged ETFs this year are health care-related plays and several of those funds were among the 10 best performers

]]>
<![CDATA[A Look Ahead: This Week's ETFs to Watch]]> Last week was an uneventful one, but when the closing bell rang Friday, the Dow Jones Industrial Average had risen 0.1 percent for the week, the S&P 500 was flat and the Nasdaq Composite was the leader with a gain of 0.7 percent.

The coming week promises to be a far

]]>
<![CDATA[Which Pharmaceutical ETF Is Leading In Inflows? PJP vs. IHE vs. XPH]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[S&P Highlights Biotech ETFs]]>  

Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks and ETFs have been stellar performers in 2013.

Recently, it was an announcement by Vertex (NASDAQ: VRTX) that its cystic fibrosis

]]>
<![CDATA[Issuer Spotlight: Invesco PowerShares]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[Earnings Trigger Volume Spike in Pharma ETF]]> On Tuesday, it was Pfizer (NYSE: PFE).

Wednesday, it is Merck (NYSE: MRK). Earnings reports from the two pharmaceuticals giants and Dow components have triggered two consecutive volume spikes in the Market Vectors Pharmaceuticals ETF (NYSE: PPH), an arguably under-appreciated play on one this

]]>
<![CDATA[Head-To-Head: Healthcare Industry Standouts]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[ETF Showdown: A Pharma Fight]]> Much has been made of low volatility sectors leading U.S. equities to new all-time highs. Sectors such as consumer staples and utilities are driving the broader market higher.

Health care is certainly in the conversation as well, and it is not just biotech names that are leading this sector's

]]>
<![CDATA[3 Best (And 3 Worst) ETF Performers Over The Last 3 Years]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[Obama Victory Puts Healthcare ETFs In Focus]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[Election Could Make or Break Health Care ETFs]]> ]]> <![CDATA[3 ETFs With Surprisingly Stellar 3-Year Returns]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[Biotech ETFs for an M&A Boom]]> ]]> <![CDATA[Balancing your portfolio for spring]]> <![CDATA[10 Equity ETFs That Surged In 2011 (And Might Do The Same In 2012)]]> Click here to read the original article on ETFdb.com.

Related Posts:

Advertisement

]]>
<![CDATA[Utilities, Consumer and Pharma ETFs Lead 2011]]> ]]> <![CDATA[New Pharma ETN (DRGS) Hits The Market]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[Bright Spots In The ETF Landscape: Five Funds Holding Their Value In A Wild 2011]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[The Pharma Four: Similar ETFs, Different Returns]]> Click here to read the original article on ETFdb.com.

Related Posts:

Advertisement

]]>
<![CDATA[Battening down the hatches for market storms]]> <![CDATA[Pharmaceutical ETFs Look to the Future]]> ]]> <![CDATA[Sector ETFs to Play the State of the Union Address]]> ]]> <![CDATA[Health Care ETFs Jump As Changes Kick In]]> ]]> <![CDATA[Why ETFs Are Mixed on Last Day of the Year]]> ]]> <![CDATA[2011 Could Be Health Care ETFs’ Year]]> ]]> <![CDATA[Pharmaceutical ETFs: Drug Companies Roar Back]]> ]]> <![CDATA[Why Health Care ETFs May Be In the Clear]]> ]]> <![CDATA[Pharma ETFs Find New Avenues of Growth]]> ]]> <![CDATA[Health Care ETFs: Next Up, Emerging Markets]]> ]]> <![CDATA[ETFs for a Changing Pharma Landscape]]> ]]> <![CDATA[The Bulls May Prevail: Pharmaceutical ETFs]]> <![CDATA[Health Care Reform ETF Winners and Losers]]> <![CDATA[4 ETFs for an Uncertain Future]]> <![CDATA[Emerging Markets: The Next Big Driver of Pharmaceutical, Biotech ETFs?]]> <![CDATA[Stocks, ETFs Move Higher as Trade Gap Narrows]]> <![CDATA[ETFs to Play Obama’s New Policies]]>